Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.3012
+0.0212 (7.57%)
At close: Feb 25, 2026, 4:00 PM EST
0.3078
+0.0066 (2.19%)
After-hours: Feb 25, 2026, 5:37 PM EST

Plus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5378111610
Market Cap Growth
629.91%-14.33%-25.69%-33.96%67.05%6.69%
Enterprise Value
3951-429
Last Close Price
0.281.151.754.7515.7530.30
PS Ratio
9.421.161.6147.55-31.86
PB Ratio
7.29-0.76-5.871.651.493.19
P/TBV Ratio
11.50--1.781.553.75
EV/Sales Ratio
7.480.930.30--29.48
Debt / Equity Ratio
1.27-0.38-3.100.880.652.31
Net Debt / Equity Ratio
-2.010.033.24-1.94-1.05-0.44
Net Debt / EBITDA Ratio
0.790.020.350.650.970.16
Net Debt / FCF Ratio
0.650.020.340.931.090.16
Asset Turnover
0.410.650.280.01-0.02
Quick Ratio
1.220.270.801.533.140.98
Current Ratio
1.290.340.921.843.361.07
Return on Equity (ROE)
---522.50%-234.65%-193.25%-393.27%
Return on Assets (ROA)
-65.58%-101.93%-47.23%-53.74%-44.65%-31.14%
Return on Capital Employed (ROCE)
-266.20%164.80%-2015.30%-164.10%-75.60%-246.90%
Earnings Yield
-41.54%-191.39%-168.24%-190.35%-83.08%-85.36%
FCF Yield
-31.85%-157.80%-164.38%-126.56%-64.63%-88.32%
Buyback Yield / Dilution
-682.06%-145.18%-79.45%-117.18%-173.03%-219.93%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q